Theeraya Simawaranon

Theeraya Simawaranon

Auto-generated profile, based on publicly available information

Theeraya Simawaranon

Suranaree University of Technology, Nakhon Ratchasima, Thailand

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
TTTaweesak Tongtawee
Taweesak Tongtawee
TSTheeraya Simawaranon
Theeraya Simawaranon
WWWareeporn Wattanawongdon
Wareeporn Wattanawongdon
CDChavaboon Dechsukhum
Chavaboon Dechsukhum
WLWilairat Leeanansaksiri
Wilairat Leeanansaksiri
Background/Aims: Genetic polymorphisms in Toll-like receptors (TLRs) are important influence on gastric lesion development and Helicobacter pylori susceptibility. Materials and Methods: TLR2 rs3804099 and rs3804100 and TLR4 rs10759932 were determined in a total of 400 patients. The association among genotypes and the risk of gastric lesion development and H. pylori susceptibility were evaluated by the odds ratios (ORs) and 95% confidence intervals (95% CIs) from logistic regression analyses. Results: TLR4 rs10759932, C/C homozygous genotype was associated with an increased risk of premalignant/malignant (OR=2.48, 95% CI=1.96-4.62, p=0.015). The recessive model of TLR4 rs10759932 showed a decreased risk of H. pylori susceptibility (adjusted OR=0.52, 95% CI=0.38-0.82, p=0.046). Meanwhile, the recessive model was associated with an increased risk of non-malignant (OR=3.46, 95% CI=2.25-5.67, p=0.001). In subjects with H. pylori infection, the recessive model was associated with an increased risk of non-malignant (OR=2.28, 95% CI=1.24-3.57, p=0.001) and premalignant/malignant (OR=1.83, 95% CI=1.16-2.84, p=0.027). Conclusion: TLR4 rs10759932, but not TLR2 rs3804099 and rs3804100, was associated with risk of premalignant and/or malignant and H. pylori susceptibility. H. pylori infection seems to contribute to chronic gastritis, and premalignant/malignant supported the development of the premalignant/malignant lesions involved in H. pylori infection that is critical to gastric cancer in Thai patients. Cite this article as: Tongtawee T, Simawaranon T, Wattanawongdon W, Dechsukhum C, Leeanansaksiri W. Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer. Turk J Gastroenterol 2019; 30: 15-20.

15 September 2018 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
TTTaweesak Tongtawee
Taweesak Tongtawee
TSTheeraya Simawaranon
Theeraya Simawaranon
WWWareporn Wattanawongdon
Wareporn Wattanawongdon
Background/Aims: Helicobacter pylori infection is a risk factor for gastric cancer and colorectal cancer (CRC). MDM2 SNP309 G/G homozygosity is known to be the genetic background that influences the severity of inflammation in the gastric mucosa, and it corresponds to CRC development. We examined the role of screening colonoscopy in H. pylori-related chronic gastritis and the association of patients who have MDM2 SNP309 G/G homozygosity and advanced colorectal neoplasia (CRN) susceptibility. Materials and Methods: A prospective cross-sectional study was used to investigate H. pylori-related gastritis in 331 consecutive asymptomatic patients who had MDM2 SNP309 G/G homozygosity and who were enrolled from November 2014 to July 2017. The MDM2 SNP309 polymorphism was genotyped by real-time PCR hybridization probe assay. Results: Totally, there were 331 patients with H. pylori-related gastritis, of whom 39 (8.76%) had advanced CRN. The H. pylori-positive group comprised 180 patients (54.36%). H. pylori infection was associated with advanced CRN (OR: 2.09, 95% CI: 1.56-2.80; p=0.01) and had an increased risk of advanced CRN (OR: 4.24, 95% CI: 1.76-5.21; p=0.01) after adjusting for confounding factors. Patients with H. pylori infection had a significantly increased risk of high-grade dysplasia or invasive adenocarcinoma (OR: 2.96, 95% CI: 1.48-4.17; p=0.03). Conclusion: Chronic gastritis patients infected with H. pylori and who had MDM2 SNP309 G/G homozygosity had an increased risk of advanced CRN, particularly high-grade dysplasia including invasive adenocarcinoma. Screening colonoscopy in these patients might benefit colorectal polyp diagnosis and prevention and early CRC treatment in the Thai population. Cite this article as: Tongtawee T, Simawaranon T, Wattanawongdon W. Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand. Turk J Gastroenterol 2018; 29: 555-60.

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
WWWareeporn Wattanawongdon
Wareeporn Wattanawongdon
TBTheeraya Simawaranon Bartpho
Theeraya Simawaranon Bartpho
TTTaweesak Tongtawee
Taweesak Tongtawee
To date, no potential markers have been established for predicting prognosis in gastric cancer. Matrix metalloproteinase‐7 (MMP‐7) has been suggested as a prognostic marker in several cancers. In this study, we aimed to determine the expression of the MMP‐7 protein and its polymorphisms in gastric cancer tissues. The association between MMP‐7 expression level and clinicopathological characteristics was also evaluated. MMP‐7 protein expression and its polymorphisms were investigated in a total of 400 patients using immunohistochemistry and TaqMan SNP genotyping assays. The correlation of MMP‐7 expression with clinicopathological characteristics, including tumor location, tumor size, histologic type, lymphatic invasion, vascular invasion, pathological T stage, pathological TNM stage, residual tumor, and CEA level, was investigated. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a multivariate Cox proportional hazards regression model. MMP‐7 expression was found in 283 of 400 (70.75%) gastric cancer tissues. Expression of MMP‐7 was significantly associated with poor clinicopathological characteristics, including vascular invasion (OR = 6.61, 95%CI = 4.26–9.89, p = 0.024), lymphatic invasion (OR = 8.17, 95%CI = 4.47–12.39, p = 0.017), undifferentiated histologic type (OR = 2.46; 95% CI, 1.31–4.52; p = 0.014), higher TNM stage (stage IV) (OR = 1.48, 95%CI = 1.08–3.08, p = 0.047), and high CEA level (OR = 5.96, 95%CI = 2.12–8.12, p = 0.026). We further observed a significant association of the variant genotype; gastric cancer patients carrying GG of MMP‐7 (‐181A/G; rs11568818) had a greater increased risk of MMP‐7 expression than did wild‐type (WT) carriers (AG: odds ratio (OR) = 5.67; 95%CI = 1.57–7.23; p = 0.024 and GG: OR = 8.32; 95%CI = 2.94–11.42; p = 0.016). These findings suggest that MMP‐7 expression can be used to predict the prognosis of gastric cancer patients.